Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Truvada price, strengths & recalls

Brand of emtricitabine / tenofovir disoproxil (generic)

Pharmacies pay $1,787.78 for 30 tablets of Truvada 200 mg / 300 mg tablet this week. The generic, emtricitabine / tenofovir disoproxil, costs pharmacies from $15.79. It has 1 recall on record, none ongoing. Its official label last changed on July 25, 2025.

Brand
Pharmacies pay$1,787.78for 30 tablets of 200 mg / 300 mg tablet-0.2% in 4 weeks
Fair cash price
$2,066.45
Strengths
1
Makers
1
Updated
Nov 11

Truvada price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
200 mg / 300 mg tablet Brand$59.59$1,787.78 / 30 tablets-0.2%No change

Truvada vs generic emtricitabine / tenofovir disoproxil

Generics have the same active ingredient, strength and form, and FDA requires them to work the same way. What pharmacies pay for each, same quantity:

StrengthBrandGenericBrand costs
200 mg / 300 mg tablet$1,787.78$15.79113.2x
GenericEmtricitabine / tenofovir disoproxil prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recalls1 recall on record, latest Oct 15, 2014

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for truvada? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJuly 25, 2025
Version32 of 25
EffectiveJul 16, 2025
Read the label

These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004

This drug has a boxed warning

WARNING: POSTTREATMENT ACUTE EXACERBATION OF HEPATITIS B and RISK OF DRUG RESISTANCE WITH USE OF TRUVADA FOR HIV-1 PRE-EXPOSURE PROPHYLAXIS (PrEP) IN UNDIAGNOSED EARLY HIV-1 INFECTION

Severe acute exacerbations of hepatitis B (HBV) have been reported in HBV-infected individuals who have discontinued TRUVADA. Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in individuals who are infected with HBV and discontinue TRUVADA. If appropriate, anti-hepatitis B therapy may be warranted [see Warnings and Precautions (5.1)].

TRUVADA used for HIV-1 PrEP must only be prescribed to individuals confirmed to be HIV-negative immediately prior to initiating and at least every 3 months during use. Drug-resistant HIV-1 variants have been identified with use of TRUVADA for HIV-1 PrEP following undetected acute HIV-1 infection. Do not initiate TRUVADA for HIV-1 PrEP if signs or symptoms of acute HIV-1 infection are present unless negative infection status is confirmed [see Warnings and Precautions (5.2)].

WARNING: POSTTREATMENT ACUTE EXACERBATION OF HEPATITIS B and RISK OF DRUG RESISTANCE WITH USE OF TRUVADA FOR HIV-1 PRE-EXPOSURE PROPHYLAXIS (PrEP) IN UNDIAGNOSED EARLY HIV-1 INFECTION

See full prescribing information for complete boxed warning.

Severe acute exacerbations of hepatitis B (HBV) have been reported in HBV-infected individuals who have discontinued TRUVADA. Hepatic function should be monitored closely in these individuals who discontinue TRUVADA. If appropriate anti-hepatitis B therapy may be warranted. (5.1)

TRUVADA used for HIV-1 PrEP must only be prescribed to individuals confirmed to be HIV-negative immediately prior to initiating and at least every 3 months during use. Drug-resistant HIV-1 variants have been identified with the use of TRUVADA for HIV-1 PrEP following undetected acute HIV-1 infection. Do not initiate TRUVADA for HIV-1 PrEP if signs or symptoms of acute HIV infection are present unless negative infection status is confirmed. (5.2)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA021752 · Gilead
First approved
August 2, 2004 (22 years ago)
Latest approved change
April 29, 2024
Approved label
PDF, Apr 30, 2024
Generic makers
11 approved generic applications on the market

Truvada questions

How much does truvada cost without insurance?

Pharmacies pay about $1,787.78 for 30 tablets of truvada 200 mg / 300 mg tablet ($59.59 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $2,066.45. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Truvada?

Yes: emtricitabine / tenofovir disoproxil. Pharmacies pay from $15.79 for it. Compare emtricitabine / tenofovir disoproxil prices.

Is truvada in shortage?

No shortage is reported for truvada right now. We check the national shortage list every day.

Has truvada been recalled?

1 recall on record, none ongoing. Recalls name specific lots - check yours.

When did the truvada label last change?

The official label was last updated on July 25, 2025 (version 32). See what changed.

Talk about truvada

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.